- Previous Close
109,300.00 - Open
108,300.00 - Bid 107,100.00 x --
- Ask 107,200.00 x --
- Day's Range
107,000.00 - 109,100.00 - 52 Week Range
83,500.00 - 126,400.00 - Volume
99,689 - Avg. Volume
263,579 - Market Cap (intraday)
11.605T - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 5, 2025 - Feb 10, 2025
- Forward Dividend & Yield 5,200.00 (4.83%)
- Ex-Dividend Date Jun 27, 2024
- 1y Target Est
131,125.00
KT&G Corporation, together with its subsidiaries, engages in the production, distribution, and sale of tobacco products in South Korea, Europe, and internationally. It provides reconstituent tobacco sheets, red ginseng, red ginseng products, other health foods, food and beverage products, health functional food products, and cosmetic and related products. The company also offers leaf tobacco cultivation support services; and develops, manufactures, and distributes drugs, bio-pharmaceuticals, over-the-counter medicines, and medical supplies and equipment. In addition, it engages in the trading, real estate, leasing, and housing businesses. Further, the company engages in hotel development and management activities. The company was formerly known as Korea Tobacco and Ginseng Corporation and changed its name to KT&G Corporation in December 2002. KT&G Corporation was founded in 1987 and is headquartered in Daejeon, South Korea.
www.ktng.comRecent News: 033780.KS
View MorePerformance Overview: 033780.KS
Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 033780.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 033780.KS
View MoreValuation Measures
Market Cap
11.61T
Enterprise Value
10.92T
Trailing P/E
12.51
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.09
Price/Book (mrq)
1.27
Enterprise Value/Revenue
1.88
Enterprise Value/EBITDA
7.17
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
5.79T
Net Income Avi to Common (ttm)
944.1B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
1.95T
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--